35 related articles for article (PubMed ID: 25954550)
1. The Effects of PCSO-524®, a Patented Marine Oil Lipid derived from the New Zealand Green Lipped Mussel (
Shei RJ; Adamic EM; Chapman RF; Mickleborough TD
Int J Exerc Sci; 2018; 11(3):669-680. PubMed ID: 29997731
[TBL] [Abstract][Full Text] [Related]
2. Perna canaliculus and the Intestinal Microbiome.
Saltzman ET; Thomsen M; Hall S; Vitetta L
Mar Drugs; 2017 Jun; 15(7):. PubMed ID: 28665349
[TBL] [Abstract][Full Text] [Related]
3. Perna canaliculus (Green-Lipped Mussel): Bioactive Components and Therapeutic Evaluation for Chronic Health Conditions.
Coulson S; Palacios T; Vitetta L
Prog Drug Res; 2015; 70():91-132. PubMed ID: 26462365
[TBL] [Abstract][Full Text] [Related]
4. Acute Hepatitis Induced by Lyprinol, the Lipid Extract of the Green-Lipped Mussel (Perna canaliculus), in a Patient with Polyarthrosis.
Abdulazim A; Hädrich M; Montani M; Semmo N
Case Reports Hepatol; 2012; 2012():135146. PubMed ID: 25954550
[TBL] [Abstract][Full Text] [Related]
5. Response to "Acute Hepatitis Induced by Lyprinol, the Lipid Extract of the Green-Lipped Mussel (Perna canaliculus), in a Patient with Polyarthrosis".
Myers SP; Oliver CJ
Case Reports Hepatol; 2014; 2014():692043. PubMed ID: 25548689
[No Abstract] [Full Text] [Related]
6. Anti-cyclooxygenase effects of lipid extracts from the New Zealand green-lipped mussel, Perna canaliculus.
McPhee S; Hodges LD; Wright PF; Wynne PM; Kalafatis N; Harney DW; Macrides TA
Comp Biochem Physiol B Biochem Mol Biol; 2007 Mar; 146(3):346-56. PubMed ID: 17197217
[TBL] [Abstract][Full Text] [Related]
7. Identification of New Potential Allergens from Green-lipped Mussel (Perna Canaliculus).
Kage P; Schubert K; Treudler R; Simon JC; Von Bergen M; Tomm J
Iran J Allergy Asthma Immunol; 2022 Dec; 21(6):711-715. PubMed ID: 36640062
[TBL] [Abstract][Full Text] [Related]
8. Furan fatty acid as an anti-inflammatory component from the green-lipped mussel Perna canaliculus.
Wakimoto T; Kondo H; Nii H; Kimura K; Egami Y; Oka Y; Yoshida M; Kida E; Ye Y; Akahoshi S; Asakawa T; Matsumura K; Ishida H; Nukaya H; Tsuji K; Kan T; Abe I
Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17533-7. PubMed ID: 21972415
[TBL] [Abstract][Full Text] [Related]
9. A phase I study to determine the safety, tolerability and maximum tolerated dose of green-lipped mussel (Perna canaliculus) lipid extract, in patients with advanced prostate and breast cancer.
Sukumaran S; Pittman KB; Patterson WK; Dickson J; Yeend S; Townsend A; Broadbridge V; Price TJ
Ann Oncol; 2010 May; 21(5):1089-93. PubMed ID: 19846468
[TBL] [Abstract][Full Text] [Related]
10. Lyprinol-is it a useful anti-inflammatory agent?
Doggrell SA
Evid Based Complement Alternat Med; 2011; 2011():307121. PubMed ID: 19383840
[TBL] [Abstract][Full Text] [Related]
11. Treatment of asthma with lipid extract of New Zealand green-lipped mussel: a randomised clinical trial.
Emelyanov A; Fedoseev G; Krasnoschekova O; Abulimity A; Trendeleva T; Barnes PJ
Eur Respir J; 2002 Sep; 20(3):596-600. PubMed ID: 12358334
[TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory effects of a stabilized lipid extract of Perna canaliculus (Lyprinol).
Halpern GM
Allerg Immunol (Paris); 2000 Sep; 32(7):272-8. PubMed ID: 11094640
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
